Networking for ovarian rare tumors: a significant breakthrough improving disease management.
Fiche publication
Date publication
avril 2017
Journal
Annals of oncology : official journal of the European Society for Medical Oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr AVEROUS Gerlinde, Pr KURTZ Jean-Emmanuel
Tous les auteurs :
Chiannilkulchai N, Pautier P, Genestie C, Bats AS, Vacher-Lavenu MC, Devouassoux-Shisheboran M, Treilleux I, Floquet A, Croce S, Ferron G, Mery E, Pomel C, Penault-Llorca F, Lefeuvre-Plesse C, Henno S, Leblanc E, Lemaire AS, Averous G, Kurtz JE, Ray-Coquard I
Lien Pubmed
Résumé
Rare ovarian tumors represent >20% of all ovarian cancers. Given the rarity of these tumors, natural history, prognostic factors are not clearly identified. The extreme variability of patients (age, histological subtypes, stage) induces multiple and complex therapeutic strategies.
Mots clés
clinical practice guidelines, gynecological rare cancers, national network, ovarian rare tumors, reference centers
Référence
Ann. Oncol.. 2017 Apr;: